Test and develop a stomach cancer detection kit
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study looks for marker signals from stomach cancer tissue to improve a detection kit. You may be asked to provide tissue samples, especially if you have a new stomach cancer diagnosis and have not had anti-cancer treatment yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a stomach cancer diagnosis confirmed by pathology (for patients) or you are generally healthy (for healthy volunteers).
- You can provide enough tissue samples for the study.
- You have not received any anti-cancer treatments yet, such as surgery, chemotherapy, radiation, targeted therapy, immunotherapy, biologic therapy, or cancer-related Chinese medicine.
- You have not joined another clinical trial in the past 90 days and have not had major surgery in the past 90 days.
- You do not have a history of other cancers, autoimmune diseases, or allergies that could affect participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to find stomach (gastric) cancer early using a simple blood test. It may help people who have just been diagnosed with stage I, II, or III stomach cancer and have not started treatment yet.
This study looks for a blood “signature” that can spot early, risky stomach changes (before cancer) and stomach cancer. It may help clinicians diagnose earlier and decide who needs closer follow-up.
This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.
This study uses a simple blood test to look for signs of stomach (gastric) cancer early. It may help detect cancer before symptoms appear, potentially improving treatment success.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study looks for markers in the blood that could show if someone is at risk for stomach cancer or pre-cancerous changes. It aims to help catch problems earlier.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.